Jane Street’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.35M Buy
20,900
+8,700
+71% +$613K ﹤0.01% 5848
2025
Q4
$821K Sell
12,200
-64,200
-84% -$4.32M ﹤0.01% 6563
2025
Q3
$5.6M Sell
76,400
-21,400
-22% -$1.42M ﹤0.01% 3259
2025
Q2
$5.09M Buy
97,800
+6,600
+7% +$376K ﹤0.01% 2973
2025
Q1
$5.82M Buy
91,200
+38,600
+73% +$2.24M ﹤0.01% 2717
2024
Q4
$2.51M Sell
52,600
-63,900
-55% -$3.28M ﹤0.01% 3719
2024
Q3
$6.67M Buy
116,500
+33,600
+41% +$1.93M ﹤0.01% 2414
2024
Q2
$4.34M Sell
82,900
-93,600
-53% -$4.1M ﹤0.01% 3188
2024
Q1
$7.18M Buy
176,500
+60,300
+52% +$2.26M ﹤0.01% 2166
2023
Q4
$4.29M Sell
116,200
-4,200
-3% -$158K ﹤0.01% 3070
2023
Q3
$4.6M Buy
120,400
+13,900
+13% +$569K ﹤0.01% 2725
2023
Q2
$3.84M Sell
106,500
-33,300
-24% -$1.14M ﹤0.01% 3121
2023
Q1
$5.34M Buy
139,800
+58,300
+72% +$2.73M ﹤0.01% 2353
2022
Q4
$4.64M Sell
81,500
-14,700
-15% -$753K ﹤0.01% 2591
2022
Q3
$3.8M Sell
96,200
-95,600
-50% -$4.23M ﹤0.01% 3061
2022
Q2
$8.44M Buy
191,800
+162,600
+557% +$7.03M ﹤0.01% 1946
2022
Q1
$1.16M Sell
29,200
-45,600
-61% -$1.62M ﹤0.01% 5814
2021
Q4
$3.01M Buy
74,800
+38,600
+107% +$1.44M ﹤0.01% 3679
2021
Q3
$1.47M Sell
36,200
-16,400
-31% -$686K ﹤0.01% 5108
2021
Q2
$2.39M Buy
52,600
+42,100
+401% +$1.86M ﹤0.01% 3988
2021
Q1
$438K Sell
10,500
-50,300
-83% -$2.3M ﹤0.01% 7038
2020
Q4
$2.6M Buy
60,800
+6,900
+13% +$248K ﹤0.01% 3060
2020
Q3
$1.42M Sell
53,900
-139,000
-72% -$3.87M ﹤0.01% 3542
2020
Q2
$5.17M Buy
192,900
+182,600
+1,773% +$4.12M ﹤0.01% 1798
2020
Q1
$185K Buy
+10,300
New +$196K ﹤0.01% 4686
2019
Q2
Sell
-10,000
Closed -$161K 5369
2019
Q1
$161K Buy
+10,000
New +$162K ﹤0.01% 4702
2018
Q1
Sell
-20,400
Closed -$413K 5024
2017
Q4
$413K Sell
20,400
-3,900
-16% -$71.7K ﹤0.01% 3395
2017
Q3
$422K Buy
+24,300
New +$329K ﹤0.01% 3312

Other funds holding HALO

Jane Street's HALO Position: Q1 2026 in Review

Jane Street increased its Halozyme (HALO) stake by 406% in Q1 2026, buying an estimated $47M and bringing the position to 831,707 shares worth $53.8M. The position accounts for 0.01% of the portfolio, ranked #1012.

Jane Street first reported a position in HALO in Q2 2013 and has held it in 39 quarters since. The position peaked at $78.9M in Q3 2025. 635 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Jane Street held 831,707 shares of Halozyme worth $53.8M as of Q1 2026.
  • Jane Street bought 667,363 Halozyme shares in Q1 2026, an estimated $47M.
  • Halozyme made up 0.01% of Jane Street's portfolio in Q1 2026, its #1012 holding.
  • Jane Street first reported a position in Halozyme in Q2 2013 and has held it in 39 quarters since.
  • Jane Street's Halozyme position peaked at $78.9M in Q3 2025.
  • 635 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.